In a globally-connected world, viruses can spread quickly. From
influenza to dengue fever to herpes to HIV, viral contagions can spread
at an alarming pace. Trouble is, doctors researching these viruses,
known as virologists, have found it quite difficult to identify
permanent cures. For example, even though doctors completely understand
how the flu virus works, millions of people still come down with a flu
bug every year. And in some instances, the flu can have fatal
consequences.
But little-known
NanoViricides (OTC: NNVC) may
have "cracked the code" when it comes to viruses. The company still has
a lot to prove, as is the case with any young biotech stock that trades
for around $1. But it appears to be making progress, and if it can
deliver on at least one of its several drugs in development, then the
upside could be significant.
(more)
Please share this article
No comments:
Post a Comment